Valeria Gigante

The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance

Hatim Sati, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2025 · 289 citations · Full text

Antimicrobial Drug Discovery, Prioritisation Study, Antimicrobial Susceptibility +14

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)

FT. Musuamba, Efthymios Manolis, Nicholas H. G. Holford et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 67 citations · Full text

Recent advances and challenges in antibacterial drug development

Valeria Gigante, Hatim Sati, Peter Beyer · ADMET & DMPK · 2022 · 39 citations · Full text

Recent Advances, Antibiotics, Medicine +9

Commentary on the MID3 Good Practices Paper

Efthymios Manolis, Jacob Brogren, Susan Cole et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 24 citations · Full text

Pharmaceutical Research, System Medicine, Simulation +19

Global testing of a consensus solubility assessment to enhance robustness of the WHO biopharmaceutical classification system

Valeria Gigante, Giovanni M. Pauletti, Sabine Kopp et al. · ADMET & DMPK · 2020 · 11 citations · Full text

Pharmaceutical Research, Consensus Solubility Assessment, Solution (Chemistry) +20